Alzheimer's disease: Five things to know
Alzheimer's disease affects more than 30 million people worldwide and remains an illness for which there is no cure.
Wed Sep 21 2022
Biogen, Eisai report design of real-world study of Alzheimer's treatment
Biogen said the main goal of the current study will be to evaluate how well Aduhelm slows the progress of Alzheimer's in dosed patients.
Fri Jul 30 2021
US approves first new Alzheimer's drug in almost two decades
Aduhelm is the first treatment directed at the underlying pathophysiology of Alzheimer's disease.
Tue Jun 08 2021